Live News EQUITY FLASH M impact Nov 19, 2026, 12:00 PM UTC Marker Therapeutics Awarded $16.2 Million CPRIT Grant for MT-601 Study The grant will advance MT-601 in the Phase 2 APOLLO study. MRKR SquawkNews Desk